nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of Dronedarone Utilization Using US Claims Databases
|
Wu, Jasmanda |
|
2014 |
36 |
2 |
p. 264-272.e2 26937 p. |
artikel |
2 |
Challenges for Academic Investigator–Initiated Pediatric Trials for Rare Diseases
|
Ahmed, Raees |
|
2014 |
36 |
2 |
p. 184-190 7 p. |
artikel |
3 |
Clinical and Economic Outcomes in Medication-Adherent and -Nonadherent Patients With Type 2 Diabetes Mellitus in the Republic of Korea
|
An, So-Yeon |
|
2014 |
36 |
2 |
p. 245-254 10 p. |
artikel |
4 |
Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
|
Lip, Gregory Y.H. |
|
2014 |
36 |
2 |
p. 192-210.e20 2.0999999999999998E22 p. |
artikel |
5 |
Effect of Gemfibrozil, Rifampicin, or Probenecid on the Pharmacokinetics of the SGLT2 Inhibitor Empagliflozin in Healthy Volunteers
|
Macha, Sreeraj |
|
2014 |
36 |
2 |
p. 280-290.e1 2621 p. |
artikel |
6 |
Erratum
|
|
|
2014 |
36 |
2 |
p. 307-308 2 p. |
artikel |
7 |
European Union Pediatric Legislation Jeopardizes Worldwide, Timely Future Advances in the Care of Children With Cancer
|
Rose, Klaus |
|
2014 |
36 |
2 |
p. 163-177 15 p. |
artikel |
8 |
Necessity of Rethinking Oral Pediatric Formulations
|
Bar-Shalom, Daniel |
|
2014 |
36 |
2 |
p. 180-183 4 p. |
artikel |
9 |
Pediatric Drug Development
|
Walson, Philip D. |
|
2014 |
36 |
2 |
p. 154-155 2 p. |
artikel |
10 |
Pediatric Drug Shortages: A Deplorable Fact and a Political Problem
|
Shader, Richard I. |
|
2014 |
36 |
2 |
p. 151-152 2 p. |
artikel |
11 |
Pharmacokinetic Properties and Bioequivalence of 2 Formulations of Valsartan 160-mg Tablets: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Korean Male Volunteers
|
Kim, Ji-Eon |
|
2014 |
36 |
2 |
p. 273-279 7 p. |
artikel |
12 |
Pharmacokinetics of a Novel Orodispersible Tablet of Sildenafil in Healthy Subjects
|
Damle, Bharat |
|
2014 |
36 |
2 |
p. 236-244 9 p. |
artikel |
13 |
Pharmacokinetics of Pilsicainide Hydrochloride for Injection in Healthy Chinese Volunteers: A Randomized, Parallel-Group, Open-Label, Single-Dose Study
|
Qiu, Qi |
|
2014 |
36 |
2 |
p. 255-263 9 p. |
artikel |
14 |
Section on Advances in Therapeutics and Technology
|
Thompson, Charles A. |
|
2014 |
36 |
2 |
p. 178-179 2 p. |
artikel |
15 |
Serum 25-Hydroxyvitamin D Level as an Independent Determinant of Quality of Life in Osteoporosis With a High Risk for Fracture
|
Ohta, Hiroaki |
|
2014 |
36 |
2 |
p. 225-235 11 p. |
artikel |
16 |
Systemic Antifungal Prophylaxis After Hematopoietic Stem Cell Transplantation: A Meta-Analysis
|
Ziakas, Panayiotis D. |
|
2014 |
36 |
2 |
p. 292-306.e1 2769 p. |
artikel |
17 |
The Pediatric Studies Initiative: After 15 Years Have We Reached the Limits of the Law?
|
Milne, Christopher-Paul |
|
2014 |
36 |
2 |
p. 156-162 7 p. |
artikel |
18 |
Tolerability and Pharmacokinetic Properties of Ondansetron Administered Subcutaneously With Recombinant Human Hyaluronidase in Minipigs and Healthy Volunteers
|
Dychter, Samuel S. |
|
2014 |
36 |
2 |
p. 211-224 14 p. |
artikel |